Literature DB >> 22316382

Measles virus, immune control, and persistence.

Diane E Griffin1, Wen-Hsuan Lin, Chien-Hsiung Pan.   

Abstract

Measles remains one of the most important causes of child morbidity and mortality worldwide with the greatest burden in the youngest children. Most acute measles deaths are owing to secondary infections that result from a poorly understood measles-induced suppression of immune responses. Young children are also vulnerable to late development of subacute sclerosing panencephalitis, a progressive, uniformly fatal neurologic disease caused by persistent measles virus (MeV) infection. During acute infection, the rash marks the appearance of the adaptive immune response and CD8(+) T cell-mediated clearance of infectious virus. However, after clearance of infectious virus, MeV RNA persists and can be detected in blood, respiratory secretions, urine, and lymphoid tissue for many weeks to months. This prolonged period of virus clearance may help to explain measles immunosuppression and the development of lifelong immunity to re-infection, as well as occasional infection of the nervous system. Once MeV infects neurons, the virus can spread trans-synaptically and the envelope proteins needed to form infectious virus are unnecessary, accumulate mutations, and can establish persistent infection. Identification of the immune mechanisms required for the clearance of MeV RNA from multiple sites will enlighten our understanding of the development of disease owing to persistent infection.
© 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22316382      PMCID: PMC3319515          DOI: 10.1111/j.1574-6976.2012.00330.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  188 in total

1.  The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity.

Authors:  Kerstin M Schuhmann; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.

Authors:  Samantha R Stubblefield Park; Mi Widness; Alan D Levine; Catherine E Patterson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Extreme mortality after first introduction of measles virus to the polynesian island of Rotuma, 1911.

Authors:  G Dennis Shanks; Seung-Eun Lee; Alan Howard; John F Brundage
Journal:  Am J Epidemiol       Date:  2011-04-15       Impact factor: 4.897

4.  Silent casualties from the measles outbreak in South Africa.

Authors:  Christine Albertyn; Helen van der Plas; Diana Hardie; Sally Candy; Tamiwe Tomoka; Edward B Leepan; Jeannine M Heckmann
Journal:  S Afr Med J       Date:  2011-05

5.  Rinderpest: the second viral disease eradicated.

Authors:  Marian C Horzinek
Journal:  Vet Microbiol       Date:  2011-02-22       Impact factor: 3.293

6.  Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell.

Authors:  R S Fujinami; M B Oldstone
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

7.  Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.

Authors:  W W Hall; R A Lamb; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin.

Authors:  K W Rammohan; H F McFarland; D E McFarlin
Journal:  Nature       Date:  1981-04-16       Impact factor: 49.962

9.  Measles virus nucleotide sequences: detection by hybridization in situ.

Authors:  A T Haase; P Ventura; C J Gibbs; W W Tourtellotte
Journal:  Science       Date:  1981-05-08       Impact factor: 47.728

10.  Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus.

Authors:  Ryan S Noyce; Daniel G Bondre; Michael N Ha; Liang-Tzung Lin; Gary Sisson; Ming-Sound Tsao; Christopher D Richardson
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

View more
  48 in total

1.  Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins.

Authors:  Benjamin O Fulton; David Sachs; Shannon M Beaty; Sohui T Won; Benhur Lee; Peter Palese; Nicholas S Heaton
Journal:  Cell Rep       Date:  2015-05-21       Impact factor: 9.423

2.  Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics.

Authors:  Wen-Hsuan W Lin; Roger D Kouyos; Robert J Adams; Bryan T Grenfell; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

Review 3.  The virome in host health and disease.

Authors:  Ken Cadwell
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

Review 4.  Keeping it in check: chronic viral infection and antiviral immunity in the brain.

Authors:  Katelyn D Miller; Matthias J Schnell; Glenn F Rall
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

Review 5.  Within host RNA virus persistence: mechanisms and consequences.

Authors:  Richard E Randall; Diane E Griffin
Journal:  Curr Opin Virol       Date:  2017-03-17       Impact factor: 7.090

6.  Measles immunometrics.

Authors:  Theodore C Pierson; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-30       Impact factor: 11.205

7.  Progress towards Rapid Detection of Measles Vaccine Strains: a Tool To Inform Public Health Interventions.

Authors:  Jill K Hacker
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

8.  Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.

Authors:  Fabrizio Angius; Heidi Smuts; Ksenia Rybkina; Debora Stelitano; Brian Eley; Jo Wilmshurst; Marion Ferren; Alexandre Lalande; Cyrille Mathieu; Anne Moscona; Branka Horvat; Takao Hashiguchi; Matteo Porotto; Diana Hardie
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

9.  Fascinating interaction between host and pathogen.

Authors:  Y K Amdekar
Journal:  Indian J Pediatr       Date:  2013-11-30       Impact factor: 1.967

10.  Mumps virus pathogenesis: Insights and knowledge gaps.

Authors:  Sigrid Gouma; Marion P G Koopmans; Rob S van Binnendijk
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.